BRIEF-Novartis announces U.S. price for newly launched biosimilar drug Zarxio

* Spokesman says wholesale acquisition cost for Zarxio 300 mcg is $275.66 and Zarxio 480mcg is $438.98 (per syringe) Further company coverage: (Reporting By Ben Hirschler)